tiprankstipranks
Trending News
More News >
Lytix Biopharma AS (DE:6BG)
:6BG
Germany Market
Advertisement

Lytix Biopharma AS (6BG) Ratios

Compare
1 Followers

Lytix Biopharma AS Ratios

DE:6BG's free cash flow for Q2 2025 was kr―. For the 2025 fiscal year, DE:6BG's free cash flow was decreased by kr and operating cash flow was kr―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.86 5.06 8.55 15.22 2.56
Quick Ratio
3.86 5.06 8.55 15.22 2.56
Cash Ratio
3.58 2.06 5.25 14.79 2.24
Solvency Ratio
-2.52 -6.92 -3.02 -3.57 -3.31
Operating Cash Flow Ratio
-1.79 -7.67 -2.96 -3.34 -1.91
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 92.34Mkr 50.77Mkr 133.66Mkr 189.62Mkr 19.89M
Leverage Ratios
Debt-to-Assets Ratio
0.02 <0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
0.03 <0.01 <0.01 0.00 0.00
Debt-to-Capital Ratio
0.03 <0.01 <0.01 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.37 1.24 1.14 1.07 1.64
Debt Service Coverage Ratio
-1.43K -1.55K -376.11 -720.61 0.00
Interest Coverage Ratio
-1.46K -1.73K -449.77 -727.05 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.04 0.01 0.04 <0.01 0.00
Net Debt to EBITDA
1.29 0.29 1.67 4.15 0.68
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
-14764.97%-2200.98%-506.96%-248.68%-1402933.33%
EBITDA Margin
-14611.84%-2176.82%-497.80%-246.34%-1402933.33%
Operating Profit Margin
-14909.54%-2425.08%-595.29%-248.54%-1412400.00%
Pretax Profit Margin
-14639.14%-2202.38%-508.29%-249.02%-1402933.33%
Net Profit Margin
-14639.14%-2202.38%-508.29%-249.02%-1402933.33%
Continuous Operations Profit Margin
-14639.14%-2202.38%-508.29%-249.02%-1402933.33%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.19%90.82%85.39%100.20%99.33%
Return on Assets (ROA)
-68.42%-137.61%-36.58%-23.69%-129.04%
Return on Equity (ROE)
-119.02%-171.28%-41.52%-25.35%-211.61%
Return on Capital Employed (ROCE)
-93.32%-188.44%-48.46%-25.31%-213.04%
Return on Invested Capital (ROIC)
-92.45%-186.80%-48.15%-25.31%-213.04%
Return on Tangible Assets
-68.42%-137.61%-36.58%-23.69%-129.04%
Earnings Yield
-16.76%-43.87%-18.21%-9.03%-5.84%
Efficiency Ratios
Receivables Turnover
0.06 0.34 2.01 4.00 <0.01
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.21 7.28 8.02 0.00 0.00
Asset Turnover
<0.01 0.06 0.07 0.10 <0.01
Working Capital Turnover Ratio
<0.01 0.04 0.07 0.18 <0.01
Cash Conversion Cycle
5.62K 1.08K 181.99 91.20 385.44K
Days of Sales Outstanding
5.62K 1.08K 181.99 91.20 385.44K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
5.62K 1.08K 181.99 91.20 385.44K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.86 -2.40 -1.33 -1.15 -0.63
Free Cash Flow Per Share
-0.86 -2.40 -1.33 -1.15 -0.63
CapEx Per Share
0.00 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -1.96K -341.73 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 -1.96K -341.73 0.00 0.00
Operating Cash Flow Coverage Ratio
-20.45 -195.06 -39.16 0.00 0.00
Operating Cash Flow to Sales Ratio
-96.92 -24.05 -4.77 -2.31 -8.12K
Free Cash Flow Yield
-11.10%-47.93%-17.15%-8.37%-3.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.97 -2.28 -5.49 -11.08 -17.12
Price-to-Sales (P/S) Ratio
873.48 50.20 27.91 27.59 240.18K
Price-to-Book (P/B) Ratio
5.58 3.90 2.28 2.81 36.23
Price-to-Free Cash Flow (P/FCF) Ratio
-9.01 -2.09 -5.83 -11.94 -29.59
Price-to-Operating Cash Flow Ratio
-9.01 -2.09 -5.85 -11.94 -29.59
Price-to-Earnings Growth (PEG) Ratio
-0.44 -0.04 1.99 -0.34 -0.58
Price-to-Fair Value
5.58 3.90 2.28 2.81 36.23
Enterprise Value Multiple
-4.68 -2.01 -3.93 -7.05 -16.44
Enterprise Value
416.06M 175.04M 215.99M 335.38M 692.10M
EV to EBITDA
-4.68 -2.01 -3.93 -7.05 -16.44
EV to Sales
684.30 43.86 19.58 17.37 230.70K
EV to Free Cash Flow
-7.06 -1.82 -4.09 -7.52 -28.43
EV to Operating Cash Flow
-7.06 -1.82 -4.10 -7.52 -28.43
Tangible Book Value Per Share
1.39 1.28 3.40 4.89 0.51
Shareholders’ Equity Per Share
1.39 1.28 3.40 4.89 0.51
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 0.10 0.28 0.50 <0.01
Net Income Per Share
-1.30 -2.19 -1.41 -1.24 -1.09
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.99 1.00 1.00 1.00 1.00
Research & Development to Revenue
96.46 15.83 4.13 1.23 5.34K
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.73 1.05 0.12 0.21 2.80K
Income Quality
0.66 1.09 0.94 0.93 0.58
Currency in NOK
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis